CS
ORIA

Clear Street’s Orion Biotech Opportunities Corp. Class A Ordinary Share ORIA Stock Holding History

Clear Street’s Portfolio ORIA Stock Details ORIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-120
Closed -$1.23K – 1574
2023
Q1 		$1.23K Buy
120
+114
+1,900% +$1.16K ﹤0.01% 928
2022
Q4 		$0 Buy
+6
New +$60 ﹤0.01% 1396

Clear Street's ORIA Position: Q2 2023 in Review

Clear Street sold out of Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) in Q2 2023, closing a stake of 120 shares — an estimated $1.23K sold.

Clear Street first reported a position in ORIA in Q4 2022 and held it in 2 quarters. The position peaked at $1.23K in Q1 2023. 0 funds tracked by Wall St. Rank hold ORIA as of Q2 2023.

  • Clear Street reported no remaining Orion Biotech Opportunities Corp. Class A Ordinary Share position as of Q2 2023 after selling out during the quarter.
  • Clear Street sold 120 Orion Biotech Opportunities Corp. Class A Ordinary Share shares in Q2 2023, an estimated $1.23K.
  • Clear Street first reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share in Q4 2022 and held it in 2 quarters.
  • Clear Street's Orion Biotech Opportunities Corp. Class A Ordinary Share position peaked at $1.23K in Q1 2023.
  • 0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Class A Ordinary Share as of Q2 2023.

Based on Clear Street's 13F filing for Q2 2023, filed 14 Aug 2023.